ConductScience.org, home

Paper39768154

Subset of DN Memory B Cells Expressing Low Levels of Inhibitory Receptor BTLA Is Enriched in SLE Patients.

Aubergeon L and 4 others. Cells, 2024. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Subset of DN Memory B Cells Expressing Low Levels of Inhibitory Receptor BTLA Is Enriched in SLE Patients. Papers, record 39768154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39768154

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Subset of DN Memory B Cells Expressing Low Levels of Inhibitory Receptor BTLA Is Enriched in SLE Patients.
PubMed
Journal
Cells
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.57, provisional
iCite
Revised in PubMed
2025-04-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aubergeon LLuciehttps://orcid.org/0000-0002-3459-7904
2Felten RRenaudhttps://orcid.org/0000-0002-4951-4032
3Gottenberg JEJacques-Eric
4Dumortier HHélène
5Monneaux FFannyhttps://orcid.org/0000-0002-2554-1300

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lupus Erythematosus, SystemicMajor topic
Receptors, ImmunologicMajor topic
Humans
Female
Adult
Male
Memory B Cells
Middle Aged
Receptors, Tumor Necrosis Factor, Member 14
Case-Control Studies

Source PubMed

Download CSV of topics

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122129255Systemic lupus erythematosus.N Engl J Med2011https://conductscience.org/library/papers/22129255PubMed
230833946The Regulatory T Cell in Active Systemic Lupus Erythematosus Patients: A Systemic Review and Meta-Analysis.Front Immunol2019https://conductscience.org/library/papers/30833946PubMed
334899718High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus Disease.Front Immunol2021https://conductscience.org/library/papers/34899718PubMed
435464461Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity.Front Immunol2022https://conductscience.org/library/papers/35464461PubMed
528886017B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis.PLoS One2017https://conductscience.org/library/papers/28886017PubMed
633028979Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19.Nat Immunol2020https://conductscience.org/library/papers/33028979PubMed
737300833Extrafollicular IgD-CD27-CXCR5-CD11c- DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19.Cell Rep2023https://conductscience.org/library/papers/37300833PubMed
815701725Identification and characterization of circulating human transitional B cells.Blood2005https://conductscience.org/library/papers/15701725PubMed
911067960Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus.J Immunol2000https://conductscience.org/library/papers/11067960PubMed
1022903545CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cells.J Mol Med (Berl)2013https://conductscience.org/library/papers/22903545PubMed
1135420627SARS-CoV-2 infection relaxes peripheral B cell tolerance.J Exp Med2022https://conductscience.org/library/papers/35420627PubMed
1219155498B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK.J Immunol2009https://conductscience.org/library/papers/19155498PubMed
1336109639Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.Nat Med2022https://conductscience.org/library/papers/36109639PubMed
1439444662Extrafollicular CD19lowCXCR5-CD11c- double negative 3 (DN3) B cells are significantly associated with disease activity in females with systemic lupus erythematosus.J Transl Autoimmun2024https://conductscience.org/library/papers/39444662PubMed
1538676311B- and T-Lymphocyte Attenuator in Systemic Lupus Erythematosus Disease Pathogenesis.Clin Pharmacol Ther2024https://conductscience.org/library/papers/38676311PubMed
168958217B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events.J Clin Invest1996https://conductscience.org/library/papers/8958217PubMed
1735537322The role of the BTLA-HVEM complex in the pathogenesis of autoimmune diseases.Cell Immunol2022https://conductscience.org/library/papers/35537322PubMed
1835507291Plasmablast-like Phenotype Among Antigen-Experienced CXCR5-CD19low B Cells in Systemic Lupus Erythematosus.Arthritis Rheumatol2022https://conductscience.org/library/papers/35507291PubMed
1932775467Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients.J Immunol Res2020https://conductscience.org/library/papers/32775467PubMed
2012796776BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.Nat Immunol2003https://conductscience.org/library/papers/12796776PubMed

See all 51 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
41828562Early Marrow Microenvironment Immune Patterns After Hematopoietic Stem Cell Transplant in Pediatric Acute Lymphoblastic Leukemia Are Associated with Later Development of Chronic GvHD and Relapse.Int J Mol Sci2026https://conductscience.org/library/papers/41828562PubMed
41373483BTLA-Expressing Memory B Cells Are Associated with Belimumab-Induced Improvement in Systemic Lupus Erythematosus.Int J Mol Sci2025https://conductscience.org/library/papers/41373483PubMed
40317077Targeting immune checkpoints in hepatocellular carcinoma therapy: toward combination strategies with curative potential.Exp Hematol Oncol2025https://conductscience.org/library/papers/40317077PubMed
39845702Targeting B and T Lymphocyte Attenuator Regulates Lupus Disease Development in NZB/W Mice.Immunotargets Ther2025https://conductscience.org/library/papers/39845702PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BTLA151888PubTator's text mininghttps://conductscience.org/library/genes/151888NCBI Gene
CD27939PubTator's text mininghttps://conductscience.org/library/genes/939NCBI Gene
TNFRSF148764PubTator's text mininghttps://conductscience.org/library/genes/8764NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39768154

GET https://conductscience.org/api/papers/v1/39768154/references?page=2